Clinical trial

Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients

NCT03682224

Study summary

ClinicalTrials.gov

Exparel and Marcaine for Pain Management in Thoracoscopic Lobectomy Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Liposomal Bupivacaine Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Bupivacaine-Epinephrine Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-07-05

PhasePHASE3

Conditions

Non Small Cell Lung Cancerunresolved

Lung Cancer Stage 1unresolved

Interventions

Liposomal BupivacaineDRUG

Bupivacaine-EpinephrineDRUG

Sponsors & collaborators

Southern Illinois Universitylead sponsor

Mapped research locations

SpringfieldIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03682224 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.